Galmed Pharmaceuticals' IPO

Galmed Pharmaceuticals raised a round of funding on March 13, 2014. Investors include Public.

Galmed Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of a novel, once-daily, oral therapy for the treatment of liver diseases and chole…

Articles about Galmed Pharmaceuticals' IPO: